ATLAS Drug Eluting Coronary Stent System Cobalt Chromium
A cobalt-chromium coronary stent delivering durable radial strength na excellent trackability, suited for changamano au kuhesabiwa coronary lesions while ensuring minimal recoil.
The ATLAS Drug Eluting Coronary Stent System is a next-generation cobalt-chromium (CoCr) stent platform coated with a sirolimus formulation (1 µg/mm²) designed to reduce restenosis in patients with coronary artery disease. By combining advanced laser-cutting technology and a clinically proven antiproliferative drug, the ATLAS system delivers durable vessel patency and a high safety profile in both de novo lesions and in-stent restenosis scenarios.
Cobalt-Chromium Alloy (L605) Construction
- Ensures exceptional strength-to-thickness ratio, enabling thinner struts without compromising radial force.
- Exhibits excellent corrosion resistance and biocompatibility for a stable healing environment.
Laser-Cut Stent Design
- Precision machining yields consistent strut geometry, promoting uniform drug distribution and an even healing surface along the vessel wall.
- Enhances stent deliverability, allowing smooth passage through calcified or tortuous coronary segments.
Sirolimus Elution Profile
- 1 µg/mm² of sirolimus is coated onto the stent’s surface, ensuring a sustained, controlled release that minimizes in-stent neointimal growth.
- Controlled drug release aids in rapid endothelialization, lowering the risk of late stent thrombosis.
Radiopaque Pt-Ir Markers
- Platinum-iridium markers at stent edges enable precise visibility under fluoroscopy.
- Facilitates accurate positioning during percutaneous coronary intervention (PCI) procedures.
High-Pressure Capability
interventional cardiologists flexibility to optimize stent expansion based on lesion complexity.
Vipimo | Maelezo / Thamani |
Jina la Bidhaa | Atlas Coronary Stent (Cobalt Chromium) |
Stent Type | Balloon-Expandable Coronary Stent |
Nyenzo | Cobalt-Chromium Alloy |
Strut Thickness | ~80 µm (typical) |
Kubuni | Open-cell or hybrid-cell architecture (depending on exact model) |
Nominal Pressure (NP) | 9–10 atm |
Rated Burst Pressure (RBP) | ~14–16 atm |
Stent Delivery System | Rapid-Exchange (RX) or Over-the-Wire (OTW), typically 140 cm shaft length |
Utangamano wa Mwongozo | 0.014” |
Stent Surface | Bare-metal or optional drug-eluting polymer (if applicable) |
Viashiria | Coronary artery lesion scaffolding, single or multivessel disease, potential usage in small/medium/large vessels |
Contraindications | Lesions unsuited for balloon-expandable stent therapy (e.g., severely calcified, left main trunk, etc.), or as per physician discretion |
Kuzaa | Asiyezaa (Ethilini Oksidi) |
Matumizi Moja | Ndiyo |
Maisha ya Rafu | 2–3 years (depending on final packaging and polymer, if any) |
Joto la Uendeshaji | Recommended 15–25 °C for storage |
Misimbo ya Kina ya Kuagiza na Bidhaa kwa Kutegemea Ukubwa
Stent Diameter (mm) | Stent Length (mm) | Nominal Pressure (atm) | RBP (atm) | Kanuni ya Bidhaa |
2.00 | 8 | 9 | 14 | ATLS-CC-2.00x08 |
2.00 | 12 | 9 | 14 | ATLS-CC-2.00x12 |
2.00 | 15 | 9 | 14 | ATLS-CC-2.00x15 |
2.00 | 18 | 10 | 16 | ATLS-CC-2.00x18 |
2.00 | 24 | 10 | 16 | ATLS-CC-2.00x24 |
2.00 | 28 | 10 | 16 | ATLS-CC-2.00x28 |
2.00 | 32 | 10 | 16 | ATLS-CC-2.00x32 |
2.00 | 38 | 10 | 16 | ATLS-CC-2.00x38 |
2.25 | 8 | 9 | 14 | ATLS-CC-2.25x08 |
2.25 | 12 | 9 | 14 | ATLS-CC-2.25x12 |
2.25 | 15 | 9 | 14 | ATLS-CC-2.25x15 |
2.25 | 18 | 10 | 16 | ATLS-CC-2.25x18 |
2.25 | 24 | 10 | 16 | ATLS-CC-2.25x24 |
2.25 | 28 | 10 | 16 | ATLS-CC-2.25x28 |
2.25 | 32 | 10 | 16 | ATLS-CC-2.25x32 |
2.25 | 38 | 10 | 16 | ATLS-CC-2.25x38 |
2.50 | 8 | 9 | 14 | ATLS-CC-2.50x08 |
2.50 | 12 | 9 | 14 | ATLS-CC-2.50x12 |
2.50 | 15 | 9 | 14 | ATLS-CC-2.50x15 |
2.50 | 18 | 10 | 16 | ATLS-CC-2.50x18 |
2.50 | 24 | 10 | 16 | ATLS-CC-2.50x24 |
2.50 | 28 | 10 | 16 | ATLS-CC-2.50x28 |
2.50 | 32 | 10 | 16 | ATLS-CC-2.50x32 |
2.50 | 38 | 10 | 16 | ATLS-CC-2.50x38 |
2.75 | 8 | 9 | 14 | ATLS-CC-2.75x08 |
2.75 | 12 | 9 | 14 | ATLS-CC-2.75x12 |
2.75 | 15 | 9 | 14 | ATLS-CC-2.75x15 |
2.75 | 18 | 10 | 16 | ATLS-CC-2.75x18 |
2.75 | 24 | 10 | 16 | ATLS-CC-2.75x24 |
2.75 | 28 | 10 | 16 | ATLS-CC-2.75x28 |
2.75 | 32 | 10 | 16 | ATLS-CC-2.75x32 |
2.75 | 38 | 10 | 16 | ATLS-CC-2.75x38 |
3.00 | 8 | 9 | 14 | ATLS-CC-3.00x08 |
3.00 | 12 | 9 | 14 | ATLS-CC-3.00x12 |
3.00 | 15 | 9 | 14 | ATLS-CC-3.00x15 |
3.00 | 18 | 10 | 16 | ATLS-CC-3.00x18 |
3.00 | 24 | 10 | 16 | ATLS-CC-3.00x24 |
3.00 | 28 | 10 | 16 | ATLS-CC-3.00x28 |
3.00 | 32 | 10 | 16 | ATLS-CC-3.00x32 |
3.00 | 38 | 10 | 16 | ATLS-CC-3.00x38 |
3.25 | 12 | 9 | 14 | ATLS-CC-3.25x12 |
3.25 | 15 | 9 | 14 | ATLS-CC-3.25x15 |
3.25 | 18 | 10 | 16 | ATLS-CC-3.25x18 |
3.25 | 24 | 10 | 16 | ATLS-CC-3.25x24 |
3.25 | 28 | 10 | 16 | ATLS-CC-3.25x28 |
3.25 | 32 | 10 | 16 | ATLS-CC-3.25x32 |
3.25 | 38 | 10 | 16 | ATLS-CC-3.25x38 |
3.50 | 8 | 9 | 14 | ATLS-CC-3.50x08 |
3.50 | 12 | 9 | 14 | ATLS-CC-3.50x12 |
3.50 | 15 | 9 | 14 | ATLS-CC-3.50x15 |
3.50 | 18 | 10 | 16 | ATLS-CC-3.50x18 |
3.50 | 24 | 10 | 16 | ATLS-CC-3.50x24 |
3.50 | 28 | 10 | 16 | ATLS-CC-3.50x28 |
3.50 | 32 | 10 | 16 | ATLS-CC-3.50x32 |
3.50 | 38 | 10 | 16 | ATLS-CC-3.50x38 |
4.00 | 8 | 9 | 14 | ATLS-CC-4.00x08 |
4.00 | 12 | 9 | 14 | ATLS-CC-4.00x12 |
4.00 | 15 | 9 | 14 | ATLS-CC-4.00x15 |
4.00 | 18 | 10 | 16 | ATLS-CC-4.00x18 |
4.00 | 24 | 10 | 16 | ATLS-CC-4.00x24 |
4.00 | 28 | 10 | 16 | ATLS-CC-4.00x28 |
4.00 | 32 | 10 | 16 | ATLS-CC-4.00x32 |
4.00 | 38 | 10 | 16 | ATLS-CC-4.00x38 |
Bidhaa zinazohusiana
-
InWIRE PTCA Guidewires
Soma zaidiMsururu wa utendaji wa juu coronary guidewires offering kudumu nitinol au isiyo na pua cores, mipako ya haidrofili, na maumbo mengi ya ncha za kuvuka kuhesabiwa au changamano coronary lesions.
-
AngioCATH Guiding Catheters
Soma zaidiHigh-performance guiding catheters with optimal torque majibu na precise tip shapes for moyo au peripheral interventions, ensuring stable device delivery and imaging clarity.
-
Atlas Endovascular Peripheral Stent Graft
Soma zaidiA covered peripheral stent graft offering salama occlusion of aneurysms or occlusive lesions in iliac au femoral segments, reducing risk of rupture or re-occlusion.
-
AngioTEN Closure Device
Soma zaidiA percutaneous vascular closure system for ateri au vena access sites, enabling salama hemostasis after catheterization or interventional procedures.